Key result
Big-ET-1 is an independent predictor of total and cardiovascular mortality, and its conjunct use with NT-proBNP improves risk stratification in patients referred for coronary angiography.
Why the study?
Does Big-ET-1 improve risk stratification for total and cardiovascular mortality when added to NT-proBNP in patients referred for coronary angiography?
Cohort (n=2,829)
Does Big-ET-1 improve risk stratification for total and cardiovascular mortality when added to NT-proBNP in patients referred for coronary angiography?
The addition of Big-ET-1 to NT-proBNP improves risk stratification for mortality in patients referred for coronary angiography.
No takes yet. Share an insight, caveat, or question.
May improve mortality risk stratification beyond NT-proBNP in angiography patients; hypothesis-generating and requires prospective validation before clinical use.
Gergei et al. (2016) conducted a cohort in Patients referred for coronary angiography (n=2,829). Big-ET-1 and NT-proBNP was evaluated on Total mortality, cardiovascular mortality, and death due to congestive heart failure. Big-ET-1 is an independent predictor of total and cardiovascular mortality, and its conjunct use with NT-proBNP improves risk stratification in patients referred for coronary angiography.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: